BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Pelthos Therapeutics Inc. (NYSE:PTHS)

1 post

Biotech NewsPelthos Therapeutics (PTHS): Zero Debt, $50M in Cash, and an FDA Greenlight—What’s Not to Love?

  • BioTech Health X
  • July 4, 2025
Pelthos Therapeutics Inc. (NYSE:PTHS) is a newly minted, revenue-ready biopharmaceutical company that sprang to life on July 2,…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Is Eli Lilly (LLY) Still a Smart Stock to Buy at Its Current Valuation?
  • Is AbbVie (ABBV) a Smart Dividend Stock to Buy Now?
  • Could Johnson & Johnson (JNJ) Be the Reliable Healthcare Investment Your Portfolio Needs?
  • Is AstraZeneca (AZN) a Good Healthcare Stock to Buy for the Long Term?
  • Is Merck & Co. (MRK) a Smart Pharmaceutical Stock to Buy Now?
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • July 31, 2026
    Is Eli Lilly (LLY) Still a Smart Stock to Buy at Its Current Valuation?
    • July 31, 2026
    Is AbbVie (ABBV) a Smart Dividend Stock to Buy Now?
    • July 31, 2026
    Could Johnson & Johnson (JNJ) Be the Reliable Healthcare Investment Your Portfolio Needs?
    • July 31, 2026
    Is AstraZeneca (AZN) a Good Healthcare Stock to Buy for the Long Term?
    • July 31, 2026
    Is Merck & Co. (MRK) a Smart Pharmaceutical Stock to Buy Now?
Recent Posts
  • Could Novartis AG (NVS) Be a Hidden Long-Term Winner in Healthcare?
    • July 31, 2026
  • What Makes Abbott (ABT) a Strong Choice for Steady Growth?
    • July 31, 2026
  • Is Novo Nordisk (NVO) Still a Good Stock to Buy After Its Massive Growth?
    • July 31, 2026
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (5)
  • Biotech News (1,038)
  • Uncategorized (2)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top